Skip to main content
. 2023 Feb 16;16(2):310. doi: 10.3390/ph16020310

Scheme 3.

Scheme 3

(a) K2CO3 anh., propargyl bromide, MeCN, 50 °C. (b) Capsule@IRA-120-Cu(0), alkyne, R-N3, MeCN, 10 h. (c) K2CO3 anh., 4-iodo-bencyl bromide, MeCN, 50 °C, 12 h. (d) K2CO3 anh., benzyl bromide, MeCN, 70 °C. (e) Capsule@IRA-120-Pd(0), methyl acrylate (exc), 90 °C, sodium acetatate, DMF/H2O, 24 h. (f) Capsule@IRA-120-Pd(0), methyl acrylate, sodium acetatate, 70 °C, DMF/H2O, 24 h. (g) Capsule@IRA-120-Pd(0), methyl acrylate (exc), sodium acetatate, 90 °C, DMF/H2O, 12 h.